Metraipolis › archive › dc_a1fc231ec3f5
Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review — Europe PMC PMID:41546841
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41546841
- DOI
- 10.1007/s00228-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T17:46:17.013Z
- SHA-256 of the archived text
8afc8eba9d475e85154aa0de7658f85e0668b9029f6d363877d24c2784d8ad5c- Stable URL of this page
https://metraipolis.com/documento/dc_a1fc231ec3f5
How to cite
Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review — Europe PMC PMID:41546841 — Europe PMC (en), https://europepmc.org/article/MED/41546841 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1fc231ec3f5 (Metraipolis archive dc_a1fc231ec3f5, sha256 8afc8eba9d475e85154aa0de7658f85e0668b9029f6d363877d24c2784d8ad5c)
BibTeX
@misc{dca1fc231ec3f5,
title = {Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review — Europe PMC PMID:41546841},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41546841},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1fc231ec3f5; sha256 8afc8eba9d475e85154aa0de7658f85e0668b9029f6d363877d24c2784d8ad5c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41546841. Agents can read the archived copy with the MCP tool read_document.